Tested Applications
| Positive WB detected in | HeLa cells |
| Positive IHC detected in | human stomach cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
15957-1-AP targets SH2D4A in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag8713 Product name: Recombinant human SH2D4A protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-338 aa of BC014525 Sequence: HSEEFTNSLKTKSQYHDLQAPDNQQTKDIWKKVAEKEELEQGSRPAPTLEEEKIRSLSSSSRNIQQMLADSINRMKAYAFHQKKESMKKKQDEEINQIEEERTKQICKSWKEDSEWQASLRKSKAADEKRRSLAKQAREDYKRLSLGAQKGRGGERLQNPLRVPQKPERPPLPPKPQFLNSGAYPQKPLRNQGVVRTLSSSAQEDIIRWFKEEQLPLRAGYQKTSDTIAPWFHGILTLKKANELLLSTGMPGSFLIRVSERIKGYALSYLSEDGCKHFLIDASADAYSFLGVDQLQHATLADLVEYHKEEPITSLGKELLLYPCGQQDQLPDYLELFE Predict reactive species |
| Full Name | SH2 domain containing 4A |
| Calculated Molecular Weight | 454 aa, 53 kDa |
| Observed Molecular Weight | 48-50 kDa |
| GenBank Accession Number | BC014525 |
| Gene Symbol | SH2D4A |
| Gene ID (NCBI) | 63898 |
| RRID | AB_2286025 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9H788 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for SH2D4A antibody 15957-1-AP | Download protocol |
| IHC protocol for SH2D4A antibody 15957-1-AP | Download protocol |
| WB protocol for SH2D4A antibody 15957-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The SH2D4A Polyclonal antibody (Cat# 15957-1-AP) has 2 total citations. One appears in Cell Signaling (2023), investigating SH2D4A's role in inhibiting esophageal squamous cell carcinoma progression via the FAK/PI3K/AKT signaling pathway. The other is published in Aging (Albany NY) (2023), examining a genomic clustering signature related to glioma prognosis and immunotherapy response. Both studies used the antibody for human samples via IHC and WB, covering research fields of cancer biology, tumor signaling, and glioma immunotherapy.
| Species | Application | Title |
|---|---|---|
Cell Signal SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway | ||
Aging (Albany NY) Integrated clustering signature of genomic heterogeneity, stemness and tumor microenvironment predicts glioma prognosis and immunotherapy response
|







